General Information of the Compound
| Compound ID |
CP0376332
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-(1H-imidazol-5-ylmethyl)pyridine
Show/Hide
|
||||||||||||||||||
| Synonyms |
4-(1H-imidazol-4-yl-methyl)-pyridine
4-(1H-imidazol-5-ylmethyl)pyridine
4-(3H-imidazol-4-ylmethyl)pyridine
87976-03-2
BCP27655
BDBM22910
CHEBI:92859
CHEMBL82298
DFVSGZHJSIEEQQ-UHFFFAOYSA-N
F8ZT2IBM1X
GTPL4024
Immethridine
NCGC00092368-02
Pyridine, 4-(1H-imidazol-5-ylmethyl)-
Pyridine,4-(1H-imidazol-5-ylmethyl)-
SB17136
SCHEMBL845141
UNII-F8ZT2IBM1X
ZINC12956299
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C9H9N3
|
||||||||||||||||||
| Molecular Weight |
159.192
|
||||||||||||||||||
| Canonical SMILES |
C(c1cnc[nH]1)c1ccncc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C9H9N3/c1-3-10-4-2-8(1)5-9-6-11-7-12-9/h1-4,6-7H,5H2,(H,11,12)
Show/Hide
|
||||||||||||||||||
| InChIKey |
DFVSGZHJSIEEQQ-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01194, Histamine H3 receptor
Cell-based Assay
Protein ID: PT01711, Histamine H4 receptor
Clinical Information about the Compound